| 1259- | CAP, | Capsaicin inhibits HIF-1α accumulation through suppression of mitochondrial respiration in lung cancer cells |
| - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H23 | - | in-vitro, | Lung, | H2009 |
| 1264- | CAP, | Capsaicin modulates proliferation, migration, and activation of hepatic stellate cells |
| - | in-vitro, | HCC, | NA |
| 1262- | CAP, | Capsaicin Inhibits Proliferation and Induces Apoptosis in Breast Cancer by Down-Regulating FBI-1-Mediated NF-κB Pathway |
| - | vitro+vivo, | BC, | NA |
| 1260- | CAP, | Capsaicin inhibits in vitro and in vivo angiogenesis |
| - | vitro+vivo, | NA, | NA |
| 1265- | CAP, | Capsaicin shapes gut microbiota and pre-metastatic niche to facilitate cancer metastasis to liver |
| - | in-vivo, | CRC, | NA |
| 1518- | CAP, | Capsaicin-mediated tNOX (ENOX2) up-regulation enhances cell proliferation and migration in vitro and in vivo |
| - | in-vitro, | CRC, | HCT116 |
| 1517- | CAP, | Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1) |
| - | in-vitro, | Bladder, | TSGH8301 | - | in-vitro, | CRC, | T24/HTB-9 |
| 2012- | CAP, | Capsaicin induces cytotoxicity in human osteosarcoma MG63 cells through TRPV1-dependent and -independent pathways |
| - | NA, | OS, | MG63 |
| 2013- | CAP, | Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 | - | in-vivo, | NA, | NA |
| 2014- | CAP, | Role of Mitochondrial Electron Transport Chain Complexes in Capsaicin Mediated Oxidative Stress Leading to Apoptosis in Pancreatic Cancer Cells |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | Nor, | HPDE-6 | - | in-vivo, | PC, | AsPC-1 |
| 2015- | CAP, | CUR, | urea, | Anti-cancer Activity of Sustained Release Capsaicin Formulations |
| - | Review, | Var, | NA |
| 2016- | CAP, | Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin) |
| 2017- | CAP, | Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease |
| - | Review, | Var, | NA |
| 2018- | CAP, | MF, | Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma |
| - | Review, | HCC, | NA |
| 2019- | CAP, | Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer |
| - | Review, | Var, | NA |
| 2020- | CAP, | Capsaicinoids and Their Effects on Cancer: The “Double-Edged Sword” Postulate from the Molecular Scale |
| - | Review, | Var, | NA |
| 4266- | CAP, | Capsaicin effects on brain-derived neurotrophic factor in rat dorsal root ganglia and spinal cord |
| - | in-vivo, | NA, | NA |
| 5768- | CAPE, | Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 5773- | CAPE, | Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B |
| - | NA, | HCC, | SK-HEP-1 |
| 5772- | CAPE, | The Pluripotent Activities of Caffeic Acid Phenethyl Ester |
| - | Review, | Var, | NA |
| 5771- | CAPE, | PBG, | Caffeic acid phenethyl ester: Unveiling its potential as a potent apoptosis inducer for combating hypopharyngeal squamous cell carcinoma |
| - | in-vitro, | HNSCC, | NA |
| 5770- | CAPE, | Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B |
| - | in-vitro, | Nor, | NA |
| 5769- | CAPE, | Caffeic Acid Phenethyl Ester Inhibits the Proliferation of HEp2 Cells by Regulating Stat3/Plk1 Pathway and Inducing S Phase Arrest |
| - | in-vitro, | Laryn, | HEp2 |
| 5767- | CAPE, | Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer |
| - | Review, | Oral, | NA |
| 5766- | CAPE, | A Nano-Liposomal Formulation of Caffeic Acid Phenethyl Ester Modulates Nrf2 and NF-κβ Signaling and Alleviates Experimentally Induced Acute Pancreatitis in a Rat Model |
| - | in-vivo, | Nor, | NA |
| 5765- | CAPE, | Absorption properties and effects of caffeic acid phenethyl ester and its p-nitro-derivative on P-glycoprotein in Caco-2 cells and rats |
| - | vitro+vivo, | Colon, | Caco-2 |
| 5764- | CAPE, | Caffeic Acid Phenethyl Ester (CAPE), Derived from a Honeybee Product Propolis, Exhibits a Diversity of Anti-tumor Effects in Preclinical Models of Human Breast Cancer |
| - | vitro+vivo, | BC, | MCF-7 | - | NA, | BC, | MDA-MB-231 |
| - | NA, | HCC, | NA |
| 5762- | CAPE, | Caffeic acid phenethyl ester promotes oxaliplatin sensitization in colon cancer by inhibiting autophagy |
| - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | HCT116 |
| 5761- | CAPE, | Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of AMPK and Akt signaling networks |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
| 5760- | CAPE, | Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | SW480 |
| 5759- | CAPE, | CAPE is a potent and a specific inhibitor of NF-kappa B activation and this may provide the molecular basis for its multiple immunomodulatory and antiinflammatory activities. |
| - | Study, | Nor, | NA |
| 5758- | CAPE, | PBG, | Caffeic acid phenethyl ester and therapeutic potentials |
| - | Review, | Var, | NA |
| 5757- | CAPE, | Caffeic acid phenethyl ester (CAPE): pharmacodynamics and potential for therapeutic application |
| - | Review, | Nor, | NA |
| 5754- | CAPE, | Rad, | The radiosensitizing effect of Caffeic Acid Phenethyl Ester in breast cancer is dependent on p53 status |
| - | in-vivo, | BC, | MDA-MB-231 |
| 5822- | capec, | Capecitabine as Adjuvant Treatment for Stage III Colon Cancer |
| - | Trial, | Colon, | NA |
| 5821- | capec, | docx, | Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results |
| - | Trial, | BC, | NA |
| 5823- | capec, | Capecitabine: a review |
| - | Review, | CRC, | NA |
| 5879- | CAR, | Pharmacokinetic analysis of thymol, carvacrol and diallyl disulfide after intramammary and topical applications in healthy organic dairy cattle |
| - | in-vivo, | Nor, | NA |
| 5887- | CAR, | TV, | Antitumor Effects of Carvacrol and Thymol: A Systematic Review |
| - | Review, | Var, | NA |
| 5886- | CAR, | Inhibition of TRPM7 with carvacrol suppresses glioblastoma functions in vivo |
| - | in-vivo, | GBM, | U87MG | - | in-vivo, | GBM, | U251 |
| 5885- | CAR, | Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HEK293 |
| 5884- | CAR, | Carvacrol affects breast cancer cells through TRPM7 mediated cell cycle regulation |
| - | in-vitro, | BC, | BT474 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-453 |
| 5883- | CAR, | Safety and tolerability of carvacrol in healthy subjects: a phase I clinical study |
| - | Trial, | Nor, | NA |
| 5882- | CAR, | Carvacrol Promotes Cell Cycle Arrest and Apoptosis through PI3K/AKT Signaling Pathway in MCF-7 Breast Cancer Cells |
| - | in-vitro, | BC, | MCF-7 |
| 5881- | CAR, | Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties |
| - | Review, | Nor, | NA |
| 5880- | CAR, | In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Nor, | BEAS-2B | - | in-vitro, | Lung, | PC9 |
| 5888- | CAR, | Therapeutic application of carvacrol: A comprehensive review |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Diabetic, | NA | - | Review, | Park, | NA |
| 5878- | CAR, | TV, | Metabolism in rats of p-cymene derivatives: carvacrol and thymol |
| - | in-vivo, | Nor, | NA |
| 5907- | CAR, | Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2 |
| - | in-vitro, | Liver, | HepG2 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid